In the lip cancer progression model, a total of fifteen samples were analyzed and GSK3β overexpression was not observed in normal (n = 2) or hyperplasia (n = 3) samples but was observed in 70.0% (7/10) of cancer samples (p = 0.0376). This evidence concerns the gene GSK3B and cancer.